Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer [Research Articles]

This article is highlighted in the In This Issue feature, p. 1047

Source: Cancer Discovery - October 2, 2017 Category: Cancer & Oncology Authors: Haricharan, S., Punturi, N., Singh, P., Holloway, K. R., Anurag, M., Schmelz, J., Schmidt, C., Lei, J. T., Suman, V., Hunt, K., Olson, J. A., Hoog, J., Li, S., Huang, S., Edwards, D. P., Kavuri, S. M., Bainbridge, M. N., Ma, C. X., Ellis, M. J. Tags: Research Articles Source Type: research